Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma.

Li XF, Dai D, Song XY, Liu JJ, Zhu L, Zhu X, Ma W, Xu W.

Oncol Lett. 2017 May;13(5):3291-3298. doi: 10.3892/ol.2017.5808. Epub 2017 Mar 6.

2.

Alterations of the NK cell pool in HIV/HCV co-infection.

Kaczmarek DJ, Kokordelis P, Krämer B, Glässner A, Wolter F, Goeser F, Lutz P, Schwarze-Zander C, Boesecke C, Strassburg CP, Rockstroh JK, Spengler U, Nattermann J.

PLoS One. 2017 Apr 5;12(4):e0174465. doi: 10.1371/journal.pone.0174465. eCollection 2017.

3.

IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages.

Wang X, Wang H, Liu MQ, Li JL, Zhou RH, Zhou Y, Wang YZ, Zhou W, Ho WZ.

Front Immunol. 2017 Mar 6;8:210. doi: 10.3389/fimmu.2017.00210. eCollection 2017.

4.

Suppression of autophagy by mycophenolic acid contributes to inhibition of HCV replication in human hepatoma cells.

Fang S, Su J, Liang B, Li X, Li Y, Jiang J, Huang J, Zhou B, Ning C, Li J, Ho W, Li Y, Chen H, Liang H, Ye L.

Sci Rep. 2017 Mar 9;7:44039. doi: 10.1038/srep44039.

5.

Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection.

Fan X, Zhu L, Liang H, Xie Z, Huang X, Wang S, Shen T.

Retrovirology. 2016 Nov 4;13(1):76.

6.

Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.

Fujii C, Kondo T, Ochi H, Okada Y, Hashi Y, Adachi T, Shin-Ya M, Matsumoto S, Takahashi R, Nakagawa M, Mizuno T.

Sci Rep. 2016 Oct 18;6:35314. doi: 10.1038/srep35314.

7.

Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.

Zhou Y, Wang X, Sun L, Zhou L, Ma TC, Song L, Wu JG, Li JL, Ho WZ.

FASEB J. 2016 Dec;30(12):4132-4140. Epub 2016 Sep 7.

8.

Donor-unrestricted T cells in the human CD1 system.

Huang S, Moody DB.

Immunogenetics. 2016 Aug;68(8):577-96. doi: 10.1007/s00251-016-0942-x. Epub 2016 Aug 9. Review.

9.

Immunological changes in different patient populations with chronic hepatitis C virus infection.

Szereday L, Meggyes M, Halasz M, Szekeres-Bartho J, Par A, Par G.

World J Gastroenterol. 2016 May 28;22(20):4848-59. doi: 10.3748/wjg.v22.i20.4848.

10.

CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients.

Guo C, Shen X, Fu B, Liu Y, Chen Y, Ni F, Ye Y, Sun R, Li J, Tian Z, Wei H.

Sci Rep. 2016 May 13;6:25567. doi: 10.1038/srep25567.

11.

NKT cell subsets as key participants in liver physiology and pathology.

Bandyopadhyay K, Marrero I, Kumar V.

Cell Mol Immunol. 2016 May;13(3):337-46. doi: 10.1038/cmi.2015.115. Epub 2016 Mar 14. Review.

12.

Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.

Chu PS, Ebinuma H, Nakamoto N, Sugiyama K, Usui S, Wakayama Y, Taniki N, Yamaguchi A, Shiba S, Yamagishi Y, Wakita T, Hibi T, Saito H, Kanai T.

PLoS One. 2015 May 12;10(5):e0125664. doi: 10.1371/journal.pone.0125664. eCollection 2015.

13.

The roles of endoplasmic reticulum overload response induced by HCV and NS4B protein in human hepatocyte viability and virus replication.

Kong L, Li S, Huang M, Xiong Y, Zhang Q, Ye L, Liu J, Zhu X, Sun R, Guo Y.

PLoS One. 2015 Apr 13;10(4):e0123190. doi: 10.1371/journal.pone.0123190. eCollection 2015.

14.

Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.

Liu B, Xiang Y, Zhang HS.

Mol Med Rep. 2015 Jul;12(1):105-10. doi: 10.3892/mmr.2015.3386. Epub 2015 Feb 24.

15.

Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.

Wang Y, Li J, Wang X, Ye L, Zhou Y, Ho W.

J Viral Hepat. 2013 Jun;20(6):385-94. doi: 10.1111/jvh.12040. Epub 2013 Jan 7.

16.

Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.

Wang Y, Li J, Wang X, Ye L, Zhou Y, Thomas RM, Ho W.

Innate Immun. 2014 Jan;20(1):3-11. doi: 10.1177/1753425913478991. Epub 2013 Mar 25.

17.

The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy.

El-Saadany S, Ziada DH, El Bassat H, Farrag W, El-Serogy H, Eid M, Abdallah M, Ghazy M, Salem HA.

Can J Gastroenterol. 2013 Feb;27(2):e13-7.

18.

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.

Wang Y, Ye L, Wang X, Li J, Song L, Ho W.

Innate Immun. 2013;19(2):193-202. doi: 10.1177/1753425912460414. Epub 2012 Oct 11.

19.

TLR3 activation efficiency by high or low molecular mass poly I:C.

Zhou Y, Guo M, Wang X, Li J, Wang Y, Ye L, Dai M, Zhou L, Persidsky Y, Ho W.

Innate Immun. 2013;19(2):184-92. doi: 10.1177/1753425912459975. Epub 2012 Oct 3.

20.

Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.

Ye L, Li J, Zhang T, Wang X, Wang Y, Zhou Y, Liu J, Parekh HK, Ho W.

Virus Res. 2012 Sep;168(1-2):33-40. doi: 10.1016/j.virusres.2012.06.009. Epub 2012 Jun 21.

Supplemental Content

Support Center